› 3bz3

X-ray diffraction
2.2Å resolution

Crystal Structure Analysis of Focal Adhesion Kinase with a Methanesulfonamide Diaminopyrimidine Inhibitor

Released:
DOI: 10.2210/pdb3bz3/pdb
PDB entry 3bz3 coloured by chain, front view.
PDB entry 3bz3 coloured by chain, side view.
PDB entry 3bz3 coloured by chain, top view.
Source organism: Homo sapiens
Primary publication:
Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562,271.
Roberts WG, Ung E, Whalen P, Cooper B, Hulford C, Autry C, Richter D, Emerson E, Lin J, Kath J, Coleman K, Yao L, Martinez-Alsina L, Lorenzen M, Berliner M, Luzzio M, Patel N, Schmitt E, LaGreca S, Jani J, Wessel M, Marr E, Griffor M, Vajdos F
Cancer Res 68 1935-44 (2008)
PMID: 18339875

Function and Biology Details

Reaction catalysed: 
ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate
Biochemical function:
Biological process:
Cellular component:
  • not assigned
Sequence domains:
Structure domain:

Structure analysis Details

Assembly composition:
monomeric (preferred)
Assembly name:
PDBe Complex ID:
PDB-CPX-170202 (preferred)
Entry contents:
1 distinct polypeptide molecule
Macromolecule:
Focal adhesion kinase 1 Chain: A
Molecule details ›
Chain: A
Length: 276 amino acids
Theoretical weight: 31.76 KDa
Source organism: Homo sapiens
Expression system: Spodoptera frugiperda
UniProt:
  • Canonical: Q05397 (Residues: 414-689; Coverage: 26%)
Gene names: FAK, FAK1, PTK2
Sequence domains: Protein tyrosine and serine/threonine kinase
Structure domains:

Ligands and Environments

1 bound ligand:
Ligand YAM 1 x YAM
No modified residues

Experiments and Validation Details

Entry percentile scores
X-ray source: RIGAKU FR-E+ DW
Spacegroup: P21
Unit cell:
a: 45.46Å b: 47.825Å c: 63.067Å
α: 90° β: 98.43° γ: 90°
R-values:
R R work R free
0.16 0.156 0.234
Expression system: Spodoptera frugiperda

Quick links

Citations

54 review citations

FAK in cancer: mechanistic findings and clinical applications.
Sulzmaier et al. (2014)
53 more

14 mentions without citation

Drug Discovery Targeting Focal Adhesion Kinase (FAK) as a Promising Cancer Therapy.
Pang et al. (2021)
13 more